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Toward adaptive therapies: modeling evolutionary principles in anticancer therapy 
  
Abstract: 
Resistance to drug therapy is an important issue in the field of cancer research because, despite 
initial success of targeted cancer drugs, many patients will ultimately develop resistance to these 
therapies, rendering treatment ineffective. A model of cancer chemotherapy must include both 
kinetic resistance (cell-cycle mediated, [1]) and genetic resistance (acquired through random 
mutations, [2]) concepts. We present a stochastic Moran process model of tumor cell kinetics, 
coupled with a prisoner’s dilemma game-theoretic cell-cell interaction model to design 
chemotherapeutic strategies tailored to different tumor growth characteristics [3]. At each step of 
the birth-death process, two phenotypic sub-populations compete in a prisoner’s dilemma 
evolutionary game with the healthy cells playing the role of cooperators, and the cancer cells 
playing the role of defectors. Fitness, birth-death rates of the cell populations, and overall tumor 
fitness are defined via the prisoner’s dilemma payoff matrix.  
  
Using the Shannon entropy as a novel tool to quantify dosing strategies, we contrast maximum 
tolerated dose (MTD) strategies as compared with low dose, high density metronomic strategies 
(LDM) for tumors with different growth rates. Our results show that LDM strategies can 
outperform MTD strategies. The advantage is magnified for fast growing tumors that thrive on 
long periods of unhindered growth without chemotherapy drugs present and is not evident after a 
single cycle of chemotherapy, but grows after each subsequent cycle of repeated chemotherapy. 
Finally, we use the model to test various adaptive therapy techniques to exploit the evolutionary 
phenotypic cost of developing resistance. We highlight the utility, clarity, and power that models 
provide in designing chemotherapeutic schedules for tumors with different growth rates and 
develop quantitative tools to optimize these schedules for maintaining low volume tumors. 
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